Morpholine-4-carboximidamide Hydrobromide → HCID 178418872, Verbindung

HRID 8606

Reaktionsgleichung

Reaktionsgleichung von HRID 8606
CO[C:3](=[O:18])[CH:4]([O:9][C:10]1[CH:15]=[CH:14][CH:13]=[C:12]([O:16][CH3:17])[CH:11]=1)[C:5]([O:7]C)=O.C[O-].[Na+].Br.[N:23]1([C:29]([NH2:31])=[NH:30])[CH2:28][CH2:27][O:26][CH2:25][CH2:24]1>CO>[CH3:17][O:16][C:12]1[CH:11]=[C:10]([CH:15]=[CH:14][CH:13]=1)[O:9][C:4]1[C:3]([OH:18])=[N:30][C:29]([N:23]2[CH2:28][CH2:27][O:26][CH2:25][CH2:24]2)=[N:31][C:5]=1[OH:7]

Komponenten

5

Versuchsvorschrift

To a solution of dimethyl-(3-methoxyphenoxy)-malonate (11.19 g) in methanol (100 ml) was added sodium methylate (6.48 g). The yellow solution was stirred for 6 h at rt. Then, morpholine-4-carboxamidine hydrobromide (8.40 g) was added and the mixture was stirred at rt for 16 h. The solvent was removed in vacuo and the residue was dissolved in water (150 ml) and extracted twice with diethyl ether (150 ml). The aqueous phase was acidified with 10% aq. citric acid. The solid that separated was collected, washed with water, evaporated twice from EA, and dried under high vacuum to give 5-(3-methoxy-phenoxy)-2-morpholin-4-yl-pyrimidine-4,6-diol (9.66 g) as a beige powder. LC-MS: tR=2.88 min, [M+1]+=320.19, [M−1]−=318.02.

Aufarbeitung

  1. stirringthe mixture was stirred at rt for 16 h
  2. customThe solvent was removed in vacuo
  3. dissolutionthe residue was dissolved in water (150 ml)
  4. extractionextracted twice with diethyl ether (150 ml)
  5. customThe solid that separated
  6. customwas collected
  7. washwashed with water
  8. customevaporated twice from EA
  9. customdried under high vacuum

Quellen und Nachweise

ORD-Eintrag
ord-c7258cdcfc7c44909a8bab2d91687812
Quelldatensatz
uspto-grants-2006_08
Patentnummer
US07091201B2

Verknüpfte Notizen

Wird geladen…